Large-conductance Ca 2+ -activated K + (BK Ca ) channels are thought to play a key role 35 in the regulation of corpus cavernosum smooth muscle (CCSM) excitability. To date, 36 few BK Ca channel openers have been accepted for clinical development. The effect of 37 the novel BK Ca channel opener, GoSlo-SR5-130, was examined on the electrical 38 activity in isolated rabbit CCSM cells and mechanical activity in strips of rabbit 39
Introduction 62
Erectile dysfunction (ED) affects around 10% of all adult males, with the incidence 63 rising steeply with age to 57% of 70 year olds (9). While ED was previously believed 64 to be largely of psychogenic origin, it is now recognized to have a physical cause in at 65 least 80% of cases, with diabetes and vascular disease leading the way as the major 66 underlying pathologies (9). Tumescence of the penis depends on filling of vascular 67 sinusoids in the corpus cavernosum, which, in turn, depends on dilation of the 68 helicine arteries and relaxation of the trabecular smooth muscle cells that line the 69 sinusoids. ED occurs when the smooth muscle cells of these structures fail to relax 70 (2). Therefore, drugs used to treat erectile dysfunction usually target smooth muscle 71 cells. Prior to 1998, the treatment success of erectile dysfunctional was, at best, 72 limited (47) . Since then, sildenafil and other phosphodiesterase 5 inhibitors, have 73 revolutionized the treatment of erectile dysfunction (20) . However, despite their 74 success, PDE5 inhibitors are only effective in about 70% of patients and, more 75 worryingly (with the increasing incidence of type II diabetes) in only 50% of diabetics 76 (12). These drugs act by blocking the breakdown of the second messenger cGMP, 77 which is generated in response to release of nitric oxide (NO) from nerves and the 78 endothelium (2, 10). One reason why PDE 5 inhibitors are of limited success in 79 diabetics is that the NO/cGMP signaling system is impaired in these people (3) voltage-gated L-type Ca 2+ channels, thus lowering the cytosolic Ca 2+ concentration, 89 resulting in relaxation of CCSM and penile erection (36). Evidence for this 90 mechanism is supported by the fact that in Slo -/-mice, where the gene encoding the 91 pore forming α-subunit of the BK Ca channel is not expressed, there is impairment of 92 nerve-induced relaxations in CCSM, resulting in erectile dysfunction (51, 52). These 93 findings suggest that drugs that open BK Ca channels might be useful as an alternative 94 treatment for erectile dysfunction. However, despite attempts to develop therapeutic 95 BK Ca channel openers, very few have been approved for clinical development due to 96 lack of efficacy (27, 45) . 97
We have recently developed a novel series of anilinoanthraquinones, designated the 98 GoSlo-SR family, that are amongst the most potent and efficacious openers of BK Ca 99 channels reported to date (31, 38, 39, 50) . These openers can shift the voltage-100 dependent activation of BK Ca channels to within the physiological range of potentials 101 experienced by smooth muscle cell membranes in vivo, thus differentiating them from 102 many commercially available BK Ca channel openers such as NS1619 and NS11021 103 (5, 38, 39). We have shown that one of these compounds, GoSlo-SR5-130, effectively 104 relaxed strips of rabbit bladder smooth muscle, while having no direct inhibitory 105 effect on L-type Ca 2+ channels in isolated rabbit bladder smooth muscle cells (31) . 106
The aims of the current study were to 1) determine the efficacy of GoSlo-SR5-130 as 107 a BK Ca channel opener in rabbit CCSM myocytes and 2) determine its ability to relax 108 rabbit CCSM strips in vitro. GoSlo-SR5-130 was chosen, as this compound has, so 109 far, been the most efficacious of the GoSlo-SR family in intact tissue (31 Patches were held at -60 mV and the patch potential was ramped from either -100 mV 147 to +100 mV or -50 to +150 mV over 2 seconds before returning to -100 mV. The -50 148 to +150 mV ramps were normally used in 100 nM Ca 2+ (Solution D) and in low drug 149 concentrations (<3 μM), whereas the -100 mV to +100 mV ramps were normally used 150 for higher drug concentrations (3 μM -30 μM). Unless otherwise stated, all drugs 151 were applied to the patches in 100 nM Ca
2+
. Voltage ramps were repeated 15 times 152 and currents were averaged, divided by the single channel conductance at each 153 voltage and thus corrected for driving force to obtain the number of channels (n) 154
multiplied by the open probability (n.Po). Maximum n.Po was determined by bathing 155 the patch in 1 μM Ca 2+ (Solution E) and repeating the ramps. Data were fitted with the 156 Boltzmann equation of the form: 157
where V 1/2 was the membrane potential at which there was half maximal activation, K 159 the slope factor and V patch the patch potential (mV). The change in activation V 1/2 (Δ 160 V 1/2 ) caused by GoSlo-SR5-130 was obtained by subtracting the V 1/2 in control (100 161 nM Ca 2+ applied to the inside of patch, no drug) from that in the presence of the drug. 162
Voltage ramps were sufficiently slow (100 mV sec -1 ) so that the activation curves 163
were not distorted by the time constants of activation or deactivation (11). The cell membrane was perforated using amphotericin B (600 μg/ml). Current clamp 173 experiments were carried in perforated patch mode using pipette solution G and 174
Hanks solution (Solution B) in the bath (E Cl = -24 mV). 175
During experiments, the dish containing the cells was superfused with Solution B. In 176 addition, the cell under study was continuously superfused by means of a close 177 delivery system consisting of a pipette (tip diameter 200 μm) placed approximately 178 300 μm away. This could be switched, with a dead-space time of < 5 s, to a solution 179 containing a drug. All experiments were carried out at 35-37 o C. 180
Isometric Tension Recordings 181
Strips of corpus cavernosum (1 cm × 3 mm) were mounted in water-jacketed organ 182 baths, perfused with warmed Krebs solution (Solution C), adjusted to 10 mN tension 183 and allowed to equilibrate for ~60 minutes. Isometric contractions were measured 184 using a Myobath system and data were acquired using DataTrax 2 software (WPI, 185 Europe). Due to the irregular nature of the spontaneous activity of the corpus 186 cavernosum, analysis was carried out by integrating the area under the curve over a 10 187 min period before and during the application of drugs. Drugs were delivered by 188 adding them to the organ bath where they were diluted in Krebs solution to their final 189
concentration. 190

Drugs & Solutions 191
GoSlo-SR5-130 (9,10-dioxo-4-((3-(trifluoromethyl)phenyl)amino)-9,10-192 dihydroanthracene-2-sulfonic acid) was synthesized as described previously (32, 33) . 
Data Analysis and Statistics 223
Experimental series were obtained from 3 or more animals. 'n' refers to the number of 224 cells, patches or tissue strips studied. Summary data are presented as mean ± S.E.M. 225
Statistical comparisons were made using ANOVA; provided overall significance was 226 achieved (p<0.05), post-hoc comparisons were made using Bonferroni's test, taking 227 p<0.05 as significant. The effects of GoSlo-SR5-130 were quantified at a range of concentrations using 261 ramp protocols to obtain plots of n.Po (see Methods). First, a control activation curve 262 was determined in the presence of 100 nM Ca 2+ , before determining the activation 263 curve at each concentration of the drug (applied also in 100 nM Ca ). An example is 264 shown in Fig. 2A . In the presence of 100 nM Ca 2+ , currents were elicited above +50 265 mV. Increasing concentrations of GoSlo-SR5-130 resulted in a leftward shift of the 266 activation curve to more negative membrane potentials ( Fig. 2A) . The mean V 1/2 in 267 100 nM Ca 2+ was +132 ± 4 mV (n=20) and in GoSlo-SR5-130: 1 μM, +103 ± 4 mV 268 (n=10); 3 μM, +73 ± 4 mV (n=9); 10 μM, +46 ± 5 mV (n=11) and 30 μM, +14 ± 12 269 mV (n=6). A concentration-effect curve was obtained by plotting the ΔV 1/2 versus 270 concentration (see Methods). This curve was then fitted with the Hill-Langmuir 271 equation to obtain an EC 50 of 10 μM (Fig. 2B) . 272
The effect of GoSlo-SR5-130 (10 μM) was also examined in the presence of 1 μM 273 Ca 2+ (Fig. 2C) . In the experiment shown in Fig. 2C , V 1/2 in 1 μM Ca 2+ was -10 mV 274 and this shifted to -61 mV in the presence of the drug. In 6 similar experiments mean 275 V 1/2 was -4 ± 5 mV in 1 μM Ca 2+ alone and -51 ± 6 mV in 10 μM GoSlo-SR5-130 and 276
. Overall the mean ΔV 1/2 for 10 μM GoSlo-SR5-130 was -57 ± 9 mV, 277 which is less than that obtained in 100 nM Ca 2+ (-78 ± 5 mV for 10 μM GoSlo-SR5-278
130, see Fig. 2B ). 279
Effect of GoSlo-SR5-130 on STOCs 280
The effect of GoSlo-SR5-130 was examined on spontaneous transient outward 281 currents (STOC's) in the perforated patch configuration of the patch clamp in whole 282 cell experiments. In these experiments the cells were held constantly at 0 mV (=E Cl ) 283 to avoid contamination with Ca 2+ -activated Cl -currents. An example is shown in Fig.  284 3A, where it is clear that GoSlo-SR5-130 (10 μM) increased STOC activity and that 285 this effect was reversed by IbTx (300 nM). 286
As STOC activity was irregular in frequency and amplitude, data were quantified by 287 integrating the currents over 1 min periods before and during the application of drugs. 288
In 6 experiments, GoSlo-SR5-130 (10 μM) increased mean STOC activity 8-fold, 289 from 0.93 ± 0.27 nA.sec in control to 7.23 ± 2.61 nA.sec (Fig. 3B, p<0 .05). In the 290 continued presence of GoSlo-SR5-130, IbTx (300 nM) reduced STOC activity to 0.81 291 ± 0.2 nA.sec (GoSlo-SR5-130 vs IbTx and GoSlo-SR5-130: p<0.05, n=6, Fig. 3B) . 292
These data confirm that the increased STOC activity in the presence of GoSlo-SR5-293 130 is the result of the opening of BK Ca channels and that GoSlo-SR5-130 is effective 294 at increasing BK Ca channel activity, not only when applied to the cytosolic side of 295 excised patches, but also when applied extracellularly. 296
The effect of GoSlo-SR5-130 (10 μM) was tested on cells held at -24 mV, which 297 corresponds to the spontaneous depolarizations (24) and where activation of a 298 sustained L-type Ca 2+ current ('window current') is possible (33). In these 299 experiments E Cl was also adjusted to -24 mV both to mimic physiological conditions, 300
and to avoid contamination with Ca 2+ -activated Cl -currents. Fig. 3C shows an 301 example, where GoSlo-SR5-130 increased the frequency and amplitude of the 302 STOCs. As above, data were quantified by integrating the currents over 1 min 303 periods. In 8 experiments GoSlo-SR5-130 (10 μM) increased mean STOC activity 304 from 0.37 ± 0.14 nA.sec in control to 2.88 ± 0.89 nA.sec (Fig. 3D, p<0.02) . 305
Effect of GoSlo-SR5-130 on membrane potential 306
The effect of GoSlo-SR5-130 (10 μM) was also examined in current clamp mode to 307 determine if it could affect membrane potential. In current clamp, under the 308 conditions described in the Methods (K + rich pipette, E Cl = -24 mV) isolated CCSM 309 myocytes displayed fast, frequent spontaneous transient hyperpolarizations of around 310 -25 mV in amplitude (Fig. 4) . In the example shown in Fig. 4A , three different 311 applications of GoSlo-SR5-130 (10 μM) resulted in reversible hyperpolarizations of 312 up to -30 mV. Similar results were obtained in a total of 6 cells, where GoSlo-SR5-313 130 (10 μM) caused a mean hyperpolarization of -9.1 ± 1.3 mV. These data are 314 summarized in Fig. 4B . 315
Effect of GoSlo-SR5-130 on spontaneous mechanical activity 316
Rabbit corpus cavernosum displays spontaneous mechanical activity consisting of 317 phasic contractions superimposed upon tonic contractions that typically last several 318 minutes, interspersed with relaxations of similar duration (24). An example of this 319 type of activity is shown in Fig. 5A , where the contraction/relaxation period was 7-8 320 min. Addition of 10 μM GoSlo-SR5-130 reduced the amplitude and duration of the 321 contractions (Fig. 5A) . Addition of 30 μM GoSlo-SR5-130 resulted in further 322 reductions, until activity was almost completely inhibited. This effect gradually 323 reversed over several hours after wash out of the drug (Wash). 324
As a result of the irregular nature of spontaneous activity in this tissue, and variability 325 in the pattern between preparations, the mean effect of GoSlo-SR5-130 was 326 quantified by integrating the tension records over 10 min periods. in the presence of phentolamine (1 μM), atropine (1 μM), and L-NO-arginine (100 332 μM), suggesting that its effects were unlikely to have been due to modulation of nerve 333 activity or nitric oxide release from the endothelium (n=6, data not shown). 334
To test if the effects of GoSlo-SR5-130 could be attributed to an action on BK Ca 335 channels, a separate series of experiments was carried out to see if its effects were 336 reversed by IbTx (100 nM). Fig. 5C shows an example where GoSlo-SR5-130 (30 337 μM) completely inhibited all of the mechanical activity. With the addition of IbTx 338 (100 nM) the activity returned to above the control level. Summary data are shown in 339 Fig. 5D , where activity in the presence of GoSlo-SR5-130 was reversed by IbTx 340
(from 31 ± 31 mN.min to 5099 ± 1058, p<0.01, n=5). 341
Effect of GoSlo-SR5-130 on K + contractures. 342
To test the likelihood that the effects of GoSlo-SR5-130 were mediated by membrane 343 hyperpolarization, it was examined on contractures induced by 60 mM KCl. Under 344 this condition, the membrane potential would be expected to be depolarized because 345 E K is reset to a more positive value than normal (e.g -22 mV, calculated from the 346
Nernst equation, assuming [K] i = 135 mM). This would cause sustained opening of L-347
type Ca 2+ channels, resulting in a sustained contraction that should be resistant to 348 opening of K + channels, as the membrane potential is likely to be already close to E K . 349 contractures. While 10 μM produced a small inflexion in the typical record it had no 351 significant effect in 6 experiments (Fig. 6B, p>0.05 ). When the drug concentration 352 was increased to 30 μM, there was a further small relaxation. Although statistically 353 significant, (p<0.01, n=6), the effect was small ( Fig. 6B; higher concentration produced a significant effect on tension and this was small (Fig.  358   6D ; control, 10.8 ± 1.9 mN; 0.3% DMSO, 8.9 ± 1.8 mN; p<0.012; n=6). Targeting BK Ca channels would, therefore, seem to be a valid approach to developing 376 novel therapies for erectile dysfunction. 377
In the present study we have examined the effect of GoSlo-SR5-130, a novel activator 378 of BK Ca channels on single channel and whole cell currents in rabbit corpus 379 cavernosum myocytes and on tension in rabbit corpus cavernosum tissue strips. 380
Although BK Ca channels have not been previously reported in rabbit CCSM, one 381 previous study reported whole cell currents consistent with their expression (32). We 382 were able to identify single channel openings similar to BK Ca channels, in terms of 383 their conductance, Ca 2+ -sensitivity and sensitivity to penitrem A, as reported 384 previously (4, 38). These channels were activated by GoSlo-SR5-130 over a 385 concentration range of 1-30 μM, with EC 50 = 10 μM. This contrasts with EC 50 values 386 of 1.8 μM and 2.5 μM reported previously in rabbit bladder myocytes and BK Ca α-387 and β-subunits expressed in HEK 293 cells (31, 39) . However, the reduced potency in 388 the case of the corpus cavernosum is not reflected by a reduction in efficacy, as the 389 response to 30 μM GoSlo-SR5-130 was, if anything, greater in than that in bladder 390 (CCSM: ΔV 1/2 = -126 ± 3 mV; bladder: ΔV 1/2 = -121 ± 10 mV). Thus, even at low 391
] (= 100 nM), GoSlo-SR5-30 was able to shift the activation of BK Ca 392 channels into the negative range of potentials (Fig. 2) of >90% of the channels in the patch at -25 mV (see Fig. 2C ). This is an important 398 observation, as this potential is similar to the level of the spontaneous depolarizations 399 observed in rabbit corpus cavernosum using intracellular microelectrodes (24). 400
Hashitani et al. (24) found that the corpus cavernosum fired spontaneous 401 depolarizations that resulted in an almost continuous depolarized state. Presumably 402 this was due to activation of Ca 2+ -activated Cl -channels, as these have been described 403 in cavernosum of rabbits, rats and humans (13, 28) GoSlo-SR5-130 also enhanced STOCs (Fig. 3) , which are due to activation of clusters 418 of BK Ca channels by localized Ca 2+ sparks, and are believed to be an important 419 mechanism by which BK Ca channels regulate membrane potential in vascular smooth 420 muscle (26). STOCS were enhanced not only at 0 mV, but also at -24 mV, which, as 421 discussed above, is relevant regarding the ability of the compound to inhibit 422 spontaneous tone. Consistent with the fact that GoSlo-SR5-130 was able to enhance 423 STOCS, it was also able to hyperpolarize isolated CCSM myocytes (Fig. 4) . These 424 cells were about 10 to 20 mV more depolarized than the whole tissue strips described 425 GoSlo-SR5-130 also inhibited spontaneous contractions of CCSM, and this effect was 429 reversed by IbTx (Fig. 5) , suggesting the involvement of BK Ca channels. in studies where it was used to relax CCSM or penile arteries (21, 43). Other 450 compounds such as 4-aryl-3-(mercapto)quinolin-2-ones and 3-thio-quinolinones had 451 disappointing relaxant effects on corpus cavernosum, despite sometimes having quite 452 potent channel opening properties, possibly due to poor tissue penetration (7, 25). 453 NS11021 was subsequently developed as a more selective and more potent BK Ca 454 activator (5). In comparable experiments to those described in the present study 455 (inside-out patches bathed in 100 nM Ca 2+ at their cytosolic surface), the ΔV 1/2 456 achieved with 10 μM NS11021 was -35 mV, resulting in an activation V 1/2 of +95 457 mV in the presence of the drug (5). This concentration therefore only had a limited 458 ability to activate BK Ca at the negative membrane potentials experienced by smooth 459 muscle cells under normal physiological conditions. When the effects of NS11021 460 were examined in in human CCSM strips, higher concentrations of 30 and 100 μM 461 produced relaxations of 50-90% (30). However, IbTx only partially blocked the 462 relaxations in response to 30 μM NS11021 and had almost no effect on those 463 produced by 100 μM, suggesting that its actions were not confined to BK Ca (30). 464
Interestingly, NS11021 was able to relax human small penile arteries at lower 465 concentrations (3-30 μM) than those required for CCSM, but again these were only 466 partially reversed by IbTx (29) . 467
This study shows that, at least in principle, BK Ca openers could be used as an 468 alternative therapy to PDE5 inhibitors in erectile dysfunction. It would be of interest 469
in future experiments to test whether its action was additive to the effect of PDE5 
